In a deal that marks its transformation to a pure-play radiopharmaceutical company, Neoprobe (NYSE Amex:NEOP) has completed the sale of its radiation detection business to Devicor Medical Products. The deal’s value could reach $50 million for Dublin, Ohio-based Neoprobe — $30 million up front and $20 million in royalties if Devicor’s sales of the acquired […]
Mammotome, the new name for the former the breast-care business of Johnson & Johnson's Ethicon Endo-Surgery, has hired a number of senior executives as the company rounds out its leadership team.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Corrected 8:39 a.m., Aug. 4, 2010 The private equity firm behind the recent acquisition of the Ethicon Endo-Surgery breast care unit near Cincinnati, Ohio, is on its way to raising a $3 billion fund. GTCR is raising its 10th fund, according to peHUB. The Chicago firm raised $2.75 billion for its ninth fund in 2006 […]
Devicor Medical Products Group LLC, the medical device holding company that bought the breast-care business of Johnson & Johnson‘s Ethicon Endo-Surgery two weeks ago, has raised $151.5 million. Devicor Medical in Pleasant Prairie, Wisconsin raised the money from seven investors, beginning on July 9, according to a Securities and Exchange Commission (SEC) filing. Nearly $3.4 […]
Devicor Medical Products Inc., the Pleasant Valley, Wisconsin, fledgling holding company backed by Chicago private equity firm GTCR Golder Rauner LLC, has made its first acquisition: the breast care business of Johnson & Johnson’s Ethicon Endo-Surgery unit near Cincinnati, Ohio. Financial terms of the deal were not disclosed. But nearly 300 Ethicon Endo-Surgery employees who […]